Contemporary epidemiology of gout in the UK general population

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Cea Soriano, Lucía ^a   Rothenbacher, Dietrich ^b   Choi, Hyon K ^c   García Rodríguez, Luis A ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b UNIVERSITY OF ULM   (Germany)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; URICOSURIC AGENT; ANTIGOUT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GOUT; HEART FAILURE; HUMAN; HYPERTRIGLYCERIDEMIA; INCIDENCE; LIFESTYLE MODIFICATION; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; PSORIASIS; RISK FACTOR; SEX RATIO; UNITED KINGDOM; CASE CONTROL STUDY; FACTUAL DATABASE; MIDDLE AGED; RISK;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GOUT; GOUT SUPPRESSANTS; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79954419004     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3272     Document Type: Article

References (35)

1. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HRJ, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005, 64:267-272. 10.1136/ard.2004.024091, 1755343, 15647434.
2. Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003, 349:1647-1655. 10.1056/NEJMcp030733, 14573737.
3. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005, 143:499-516.
4. Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care 2005, 11:S435-442. quiz S465-468.
5. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007, 66:1311-1315. 10.1136/ard.2007.070755, 1994300, 17504843.
6. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I, . EULAR Standing Committee for International Clinical Studies Including Therapeutics EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1312-1324. 10.1136/ard.2006.055269, 1798308, 16707532, EULAR Standing Committee for International Clinical Studies Including Therapeutics.
7. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising?. J Rheumatol 2002, 29:2403-2406.
8. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966. 10.1136/ard.2007.076232, 2564789, 17981913.
9. Elliot AJ, Cross KW, Fleming DM. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis 2009, 68:1728-1733. 10.1136/ard.2008.096693, 19029167.
10. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165:742-748. 10.1001/archinte.165.7.742, 15824292.
11. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004, 12:171-177.
12. http://www.connectingforhealth.nhs.uk/systemsandservices/data/uktc/readcodes
13. http://www.firstdatabank.co.uk/8/multilex-drug-data-file
14. Meier CR, Jick H. Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol 1997, 44:175-178. 10.1046/j.1365-2125.1997.00647.x, 2042824, 9278205.
15. Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology 2007, 69:1696-1700. 10.1212/01.wnl.0000279518.10072.df, 17954784.
16. Hak AE, Curhan G, Grodstein FD, Choi HK. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 2009, 69:1305-1309. 10.1136/ard.2009.109884, 19592386.
17. Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis 2006, 65:1368-1372. 10.1136/ard.2006.051649, 1798311, 16644784.
18. Atallah AN, Guimaraes JA, Gebara M, Sustovich DR, Martinez TR, Camano L. Progesterone increases glomerular filtration rate, urinary kallikrein excretion and uric acid clearance in normal women. Braz J Med Biol Res 1988, 21:71-74.
19. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008, 10:R116. 10.1186/ar2519, 2592803, 18822120.
20. Nicholls A, Snaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973, 1:449-451. 10.1136/bmj.1.5851.449, 1588487, 4689833.
21. Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005, 17:341-345. 10.1097/01.cco.0000152664.87204.3c, 15838248.
22. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998, 57:509-510. 10.1136/ard.57.9.509, 1752735, 9849306.
23. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363:1277-1281. 10.1016/S0140-6736(04)16000-5, 15094272.
24. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007, 57:109-115. 10.1002/art.22466, 17266099.
25. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006, 8:S2. 10.1186/ar1907, 16820041.
26. Rodriguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 2010, 69:2090-2094. 10.1136/ard.2010.130013, 20570836.
27. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) 2008, 47:713-717. 10.1093/rheumatology/ken066, 18390895.
28. Ketai LH, Simon RH, Kreit JW, Grum CM. Plasma hypoxanthine and exercise. Am Rev Respir Dis 1987, 136:98-101.
29. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, Stevenson JC, Coats AJ. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997, 18:858-865.
30. Janssens HJ, van de Lisdonk EH, Janssen M, van den Hoogen HJ, Verbeek AL. Gout, not induced by diuretics? A case-control study from primary care. Ann Rheum Dis 2006, 65:1080-1083. 10.1136/ard.2005.040360, 1798248, 16291814.
31. Pascual E, Perdiguero M. Gout, diuretics and the kidney. Ann Rheum Dis 2006, 65:981-982. 10.1136/ard.2005.049023, 1798242, 16837492.
32. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int 2003, 64:1022-1026. 10.1046/j.1523-1755.2003.t01-2-00171.x, 12911552.
33. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002, 40:37-42. 10.1053/ajkd.2002.33911, 12087559.
34. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000, 11:974-979.
35. Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989, 321:287-292. 10.1056/NEJM198908033210504, 2664517.